02/24
Headlines

Finance

Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T), Rosetta Genomics (NASDAQ:ROSG), The Buckle, Inc. (NYSE:BKE), ReneSola Ltd. (NYSE:SOL)

Ryan Holtz03 mins

On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.11) by $0.14. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is -0.48%. On last trading day company shares ended up $4.18. Arena Pharmaceuticals,…

Read More

Hot Alert: DIRECTV (NASDAQ:DTV), LRAD (NASDAQ:LRAD), Cellular Dynamics International (NASDAQ:ICEL), SCYNEXIS, Inc. (NASDAQ:SCYX), Flexible Solutions International Inc. (NYSEMKT: FSI)

Adam Keintzel03 mins

On 15 AUG DIRECTV (NASDAQ:DTV) said that DIRECTV (NASDAQ:DTV) and NFL Now are teaming up to launch “The Rich Eisen Show,” a new, daily talk show featuring NFL Network’s Rich Eisen, which will premiere on Oct. 6 and air exclusively on DIRECTV’s Audience Network from noon to 3 p.m. (EDT). DIRECTV (NASDAQ:DTV) belongs to Services…

Read More

Big Movers: Nektar Therapeutics (NASDAQ:NKTR), Harmonic (NASDAQ:HLIT), Apollo Global Management (NYSE:APO), PartnerRe Ltd. (NYSE:PRE), Oil States International Inc. (NYSE:OIS)

Adam Keintzel03 mins

On 31 JULY Nektar Therapeutics (NASDAQ:NKTR) last released its earnings data on Thursday. The company reported ($0.26) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.37) by $0.11. The company had revenue of $28.50 million for the quarter, compared to the consensus estimate of $19.76 million. During the same quarter in the…

Read More

Trader’s Watch List: Morgan Stanley (NYSE:MS), Gerdau (NYSE:GGB), Camden National (NASDAQ:CAC), Mechel OAO (NYSE:MTL), American International Group, Inc. (NYSE:AIG)

John Bellich03 mins

On 20 AUG Morgan Stanley (NYSE:MS) said that it believes the readers of its report should short 10-year U.S. Treasuries and long the S&P 500. The bank uses a proprietary Real-Time Tracker to predict what Existing Home Sales will be. The RTT estimate is for +2.6 percent or 5.17 million versus consensus expectations of -0.4…

Read More

Why Need to Watch: Dipexium Pharmaceuticals(NASDAQ:DPRX), Yahoo! Inc. (NASDAQ:YHOO), UMH Properties (NYSE:UMH), Consolidated Edison, Inc. (NYSE:ED), The Medicines Company (NASDAQ:MDCO)

Jayne Crisman02 mins

On 13 AUG Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) released its earnings data on Wednesday. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.37) by $0.09. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) belongs to Healthcare sector. Its weekly performance is -2.28%. On last trading day company shares ended up $9.00. Dipexium Pharmaceuticals, Inc….

Read More

Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

Ryan Holtz03 mins

On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively.  This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists…

Read More